PBM markets lack competition, new paper finds

PBM markets lack competition, new paper finds

The American Medical Association’s research, which found that local PBM markets are highly concentrated, is more fuel for critics of the powerful drug middlemen.

PBM markets are at risk of harming patients

The American Medical Association (AMA) today published a� new annual analysis �(PDF) measuring competition in pharmacy benefit manager (PBM) markets and vertical integration of insurers with PBMs. The assessment demonstrates low competition in PBM markets across the nation and high vertical integration as the largest PBMs share ownership with health insurers. The AMA analysis adds to growing concern over anticompetitive harm resulting from low c…